Top Industry Leaders in the Paronychia treatment Market
Latest Paronychia Treatment Companies Updates:
Bausch Health expands Jublia reach: In October 2023, Jublia, their topical solution for paronychia, received marketing authorization in Canada, expanding its availability beyond the US and Europe.
Moberg Pharma strengthens MEA presence: Their agreement with Mundipharma in November 2020 grants them wider distribution of their topical nail disorder treatments throughout the Middle East and Africa.
FDA approval for dabrafenib/trametinib: In June 2022, the FDA approved this combination therapy for treating a rare form of paronychia related to BRAF gene mutations, offering hope for patients with limited treatment options.
List of Paronychia Treatment Key companies in the market:
- GlaxoSmithKline plc
- Perrigo New York, Inc.
- Jonakayem Pharma Formulation Pvt. Ltd.
- Glenmark Generics Ltd.
- Teva Pharmaceutical Industries Ltd.
- Fougera Pharmaceuticals Inc.
- Eli Lilly Company